Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Seres Therapeutics
3151
Seres Therapeutics
Technology
Biotechnology
SERES HEALTH designs and develops products that will improve the dignity for patients with stomas & ostomies
Suggest edits
Founded
2010
Raised
$267.5M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Repare Therapeutics
Indee Labs (YC W17)
Dumpling
Altius Analytics Labs
BEROCEUTICA GmbH
Integrated BioTherapeutics, Inc.
MycoWorks
Antengene Corporation
Aurealis Pharma
DNA Script
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Add round
25 Jun
2015
$134,000,000
IPO
Fidelity Investments
,
Flagship Ventures
,
Enso Ventures
,
+1
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO
Xconomy
06 Jan
2015
$65,000,000
Venture capital (Series D)
Nestlé Health Science
Seres Health Announces $65 Million Investment from Nestle Health Science
prnewswire
02 Dec
2014
$48,000,000
Venture capital (Series C)
Flagship Ventures
09 Jun
2014
$10,000,000
Venture capital (Series B)
Flagship Ventures
,
Alexandria Venture
,
Enso Ventures
,
+1
21 Nov
2013
$10,500,000
Venture capital (Series A)
Flagship Ventures
,
Enso Ventures